Reyna Chang

Reyna Chang has work experience at two companies. Reyna began working at PlateletBio in July 2021 as a Research Associate and later became a Senior Research Associate in January 2022. During their time at PlateletBio, they developed various in vitro/ex vivo assays to support IND-enabling studies and contributed to the characterization efforts of PLCs by performing in vitro assays such as antibody removal assay, ELISA, Western blot, and multiparameter flow cytometry. Reyna also independently analyzed and presented data at weekly team meetings. In March 2022, Reyna joined Prime Medicine, Inc. as an Associate Scientist II.

Reyna Chang completed their Bachelor of Science (BS) degree in Biomedical Sciences and Engineering at National Central University from 2017 to 2020. Afterward, they pursued a Master of Science (MS) degree in Biological Sciences at the University of Massachusetts Lowell from 2019 to 2021.